Treatment of branch retinal vein occlusion induced macular edema with bevacizumab

BMC Ophthalmology

Volumn 8, Issue , 2008, Pages

  Abegg, Mathias ^a   Tappeiner, Christoph ^a   Wolf Schnurrbusch, Ute ^a   Barthelmes, Daniel ^a   Wolf, Sebastian ^a   Fleischhauer, Johannes ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODILUTION; HUMAN; LOW LEVEL LASER THERAPY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THICKNESS; TREATMENT OUTCOME; VISUAL ACUITY; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; INJECTION; MIDDLE AGED; PATHOLOGY; RETINA; RETINA VEIN OCCLUSION; TIME; VITREOUS BODY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 53849117478     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-8-18     Document Type: Article

References (14)

1. Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. R David L Zangwill M Badarna Y Yassur, Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology 1988 197 2 69 74
2. Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984 98 3 271 282 6383055
3. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. O Cekic S Chang JJ Tseng GR Barile LV Del Priore H Weissman WM Schiff MD Ober, Retina 2005 25 7 851 855 10.1097/00006982-200510000-00006 16205563
4. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. H Noma H Funatsu M Yamasaki H Tsukamoto T Mimura T Sone K Jian I Sakamoto K Nakano H Yamashita, Am J Ophthalmol 2005 140 2 256 261 16086947
5. [Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]. GB Jaissle F Ziemssen K Petermeier P Szurman M Ladewig F Gelisken M Volker FG Holz KU Bartz-Schmidt, Ophthalmologe 2006 103 6 471 475 10.1007/s00347-006-1355-2 16763863
6. Clinical, Anatomic, and Electrophysiologic Evaluation Following Intravitreal Bevacizumab for Macular Edema in Retinal Vein Occlusion. SA Pai R Shetty PB Vijayan G Venkatasubramaniam NK Yadav BK Shetty RB Babu KM Narayana, Am J Ophthalmol 2007 17306753
7. Intravitreal Bevacizumab (Avastin) In The Treatment Of Macular Edema Secondary To Branch Retinal Vein Occlusion. MD Rabena DJ Pieramici AA Castellarin MA Nasir RL Avery, Retina 2007 27 4 419 425 10.1097/IAE. 0b013e318030e77e 17420692
8. Bevacizumab in retinal vein occlusion-results of a prospective case series. A Stahl H Agostini LL Hansen N Feltgen, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2007 245 10 1429 1436
9. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. TC Kreutzer CS Alge AH Wolf D Kook J Burger R Strauss C Kunze C Haritoglou A Kampik S Priglinger, The British journal of ophthalmology 2008 92 3 351 355 10.1136/bjo.2007.123513 18211925
10. Intravitreal avastin for macular edmema secondary to retinal vein occlusion - a prospective study. K Kriechbaum S Michels F Prager M Georgopoulos M Funk W Geitzenauer U Schmidt-Erfurth, The British journal of ophthalmology 2008 92 4 518 522 10.1136/bjo.2007.127282 18211942
11. COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: Results From the Pan-American Collaborative Retina Study Group at 6 Months of Follow-Up. L Wu JF Arevalo JA Roca M Maia MH Berrocal FJ Rodriguez T Evans RA Costa J Cardillo, Retina 2008 28 2 212 219 18301025
12. Ranibizumab for Macular Edema Due to Retinal Vein Occlusions; Implication of VEGF as a Critical Stimulator. PA Campochiaro G Hafiz SM Shah QD Nguyen H Ying DV Do E Quinlan I Zimmer-Galler JA Haller SD Solomon, Mol Ther 2008
13. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. D Iturralde RF Spaide CB Meyerle JM Klancnik LA Yannuzzi YL Fisher J Sorenson JS Slakter KB Freund M Cooney, Retina 2006 26 3 279 284 10.1097/00006982-200603000-00005 16508427
14. Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study. MM Moschos M Moschos, Documenta ophthalmologica 2008 116 2 147 152 10.1007/s10633-007-9110-9 18189152